Sunday, September 13, 2026

Platinum Futures Is 10% Down In The Last 21 Sessions

Platinum Futures Is 10% Down In The Last 21 Sessions

(VIANEWS) - Platinum (PL) has been up by 10.43% for the last 21 sessions. At 23:52 EST on Friday, 2 June, Platinum (PL) is $1,008.70.

Volume

Today's last reported volume for Platinum is 2100, 99.99% below its average volume of 10436129922.05.

Volatility

Platinum's last week, last month's, and last quarter's current intraday variation average was a negative 0.51%, a negative 0.39%, and a positive 1.46%, respectively.

Platinum's highest amplitude of average volatility was 0.76% (last week), 1.20% (last month), and 1.46% (last quarter), respectively.

News about

  • According to DailyForex on Thursday, 1 June, "WTI Crude Oil may see a short-term bounce as it reaches oversold conditions, while the $65 level remains a critical long-term support level. ", "The WTI Crude Oil market witnessed a significant decline during Wednesday's trading session, as it continues to grapple with challenges. "

More news about Platinum (PL).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Chip Boom Lifts Semiconductors as Export-Control Gaps Persist
AI infrastructure demand is fueling a broad semiconductor rally — Broadcom's AI chip revenue and Q4 guidance, Amazon's custom silicon crossing a $25B annual run rate, and bullish analyst calls on Micron and Sandisk tied to a memory chip boom underestimated even by bulls — with ASML rallying on sympathy. That momentum runs alongside unresolved US-China tech tensions: Belgium's arrest of a suspect for stealing chip technology for China and a blacklisted Chinese firm still acquiring Nvidia's top AI chips show export-control enforcement lagging the pace of AI chip demand.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,280 source documents archived
Query this data → isubstrate.com